0001209191-17-041610.txt : 20170623 0001209191-17-041610.hdr.sgml : 20170623 20170623141859 ACCESSION NUMBER: 0001209191-17-041610 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170619 FILED AS OF DATE: 20170623 DATE AS OF CHANGE: 20170623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XBiotech Inc. CENTRAL INDEX KEY: 0001626878 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 BUSINESS PHONE: 512-386-2930 MAIL ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCKENZIE W THORPE CENTRAL INDEX KEY: 0001211462 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37347 FILM NUMBER: 17927204 MAIL ADDRESS: STREET 1: 735 BROAD ST STREET 2: STE 1105 CITY: CHATTANOOGA STATE: TN ZIP: 37402 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-19 0 0001626878 XBiotech Inc. XBIT 0001211462 MCKENZIE W THORPE 8201 EAST RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 1 0 1 0 Stock Option 4.24 2017-06-19 4 M 0 50000 4.24 A 2018-06-19 2027-06-19 Common Stock 50000 50000 D On September 14, 2016 (the Grant Date) Fabrizio Bonanni was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market, with an expiry of ten years from the Grant Date. Half of the Options vest on December 20, 2016 and another half of the Options vest on June 20, 2017. On June 19, 2017 (the Grant Date) the reporting person was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal portions at six months and one year commencing as of the first anniversary of the Grant Date with an expiry of ten years from the Grant Date. /s/ Ashley Otero under Power of Attorney for Thorpe McKenzie 2017-06-23